On the 30 of August the inspection of the Ministry of Health of the Republic of Iraq has visited the manufacturing complex of NatiVita

In the near future, two drugs will immediately receive registration certificates: T-Mab (Trastuzumab) and B-Mab (Bevacizumab). T-Mab and B-Mab are the first drugs registered by NatiVita outside Belarus.

On the 25 of September, NatiVita took part in the first meeting of the Belarusian-Slovak Commission for Cooperation in Science and Technology in Minsk.

NatiVita team took part in the semi-marathon, which was held for the fourth time in Minsk. 

Representatives of NatiVita took part in the 6th meeting of the Uzbek-Belarusian intergovernmental commission for bilateral cooperation

Drug for multiple sclerosis treatment

• NatiVita has been granted with a product license for generic drug Glatiramer acetate brand named GLACETAT.

NatiVita became a partner of Ride4Women charity bike ride

On Sunday, July 8th, NatiVita team took part in Ride4Women charity bike ride, which goal was to attract attention to women’s health problems and inform as many people as possible that cancer could be prevented and cured.

On Saturday, July 28, the expert council of the TALENAVITA program selected the best project in the scientific session of TALENAVITA CAMP. The team-winner offered the jury a simple and potentially effective respiratory test for screening the stomach cancer.

Belarusian students will seek solutions to oncology problems in the scientific camp TALENAVITA CAMP

NatiVita became a partner of Ride4Women charity bike ride.

This Sunday, on July 8th Ride4Women charity bike ride dedicated to treatment of oncological diseases will be held supported by NatiVita.